Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by NovaBay Pharmaceuticals, Inc. < Previous 1 2 3 Next > NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets September 20, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results August 13, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 August 01, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales July 30, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option July 29, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering July 26, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day July 16, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million July 11, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities July 01, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers EYEN NBY NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions June 28, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American June 07, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates May 29, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms May 13, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results May 09, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon May 07, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024 May 03, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales April 22, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity April 19, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses April 17, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results March 26, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024 March 25, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023 March 14, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales January 30, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network January 09, 2024 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes December 06, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results November 09, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023 November 02, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs October 11, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference October 02, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft September 14, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire Tickers NBY < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.